ATI Medical-Surgical Critical Care Final
Exam: Elite 2026/2027 Test Bank
Protocol
PART I: THE PRIMER
Mastering high-acuity medical-surgical nursing transforms the amateur into the apex clinical
leader capable of averting multi-system failure. The 2026/2027 standard demands zero
hesitation, replacing academic memorization with absolute physiological command.
● Sepsis (2025/2026): Shock (MAP < 65 or Lactate ≥ 4) triggers the STAT 1-Hour Bundle;
deploy peripheral norepinephrine without waiting for central access.
● Burns: Initiate 2 mL/kg/%TBSA for adults ≥20% TBSA; abandon static formulas and
titrate hourly to a 30-50 mL/hr urine output.
● Stroke: Tenecteplase (TNK) 0.25 mg/kg is the 2026 standard for rapid bolus
administration within 4.5 hours.
● Heart Failure: SGLT2 inhibitors and ARNis are foundational across ejection fractions;
initiate simultaneously.
● Neuro: Level the External Ventricular Drain (EVD) transducer precisely to the tragus
(Foramen of Monro).
PART II: THE ELITE TEST BANK
Foundational Syntax & Application
Q1: A patient admitted with pneumonia presents with a Mean Arterial Pressure (MAP) of
58 mmHg and a serum lactate of 4.5 mmol/L. According to the 2025/2026 Surviving
Sepsis Campaign guidelines, what is the immediate classification and required timeline
for antimicrobial administration? A) Possible sepsis; 3-hour bundle initiation. B) Septic shock;
1-hour bundle initiation. C) Severe sepsis; 6-hour bundle initiation. D) Systemic Inflammatory
Response Syndrome; 3-hour bundle initiation.
● The Answer: B (Septic shock; 1-hour bundle initiation).
● Distractor Analysis: Options A and D represent outdated or incorrect stratifications. The
3-hour bundle is reserved strictly for "possible sepsis without shock" to allow for rapid
investigation. Option C uses an obsolete 6-hour metric.
● The Mentor's Analysis: The 2026 standard defines a lactate ≥4 mmol/L or hypotension
requiring vasopressors as septic shock. This is a STAT emergency demanding the 1-hour
bundle: broad-spectrum antimicrobials and fluid resuscitation immediately.
Sepsis Acuity Diagnostic Criteria Antimicrobial Timeline
Septic Shock MAP < 65 mmHg OR Lactate ≥ 1-Hour Bundle (STAT
4 mmol/L Emergency)
Possible Sepsis Hemodynamically stable, 3-Hour Bundle (Rapid
uncertain diagnosis Investigation)
,Q2: A 45-year-old male arrives at the emergency department weighing 100 kg with deep
partial-thickness burns over 40% of his Total Body Surface Area (TBSA). Utilizing the
2026 American Burn Association (ABA) Clinical Practice Guidelines, what is the initial
fluid resuscitation rate? A) 1,000 mL/hr of Lactated Ringer's. B) 2,000 mL/hr of 0.9% Normal
Saline. C) 500 mL/hr of Lactated Ringer's. D) 800 mL/hr of 5% Albumin.
● The Answer: C (500 mL/hr of Lactated Ringer's).
● Distractor Analysis: Option A uses the outdated 4 mL/kg Parkland formula (4x100x40 =
16, = 8,000 in 8 hrs = 1,000 mL/hr), which frequently causes fatal
over-resuscitation. Option B uses the wrong crystalloid. Option D introduces colloids too
early.
● The Mentor's Analysis: The 2026 ABA standard initiates resuscitation at 2
mL/kg/%TBSA. Calculation: 2 mL x 100 kg x 40 = 8,000 mL total for 24 hours. Half (4,000
mL) is given in the first 8 hours, resulting in a starting rate of 500 mL/hr. This mitigates
"fluid creep" while maintaining organ perfusion.
Q3: A patient is diagnosed with an acute ischemic stroke (AIS) 2 hours after symptom
onset. Following the 2026 AHA/ASA guidelines, which thrombolytic intervention
demonstrates superior pharmacokinetic advantages and is strongly endorsed? A)
Alteplase 0.9 mg/kg as a continuous 60-minute infusion. B) Tenecteplase 0.25 mg/kg as a single
5-10 second intravenous bolus. C) Dual antiplatelet therapy (DAPT) alone. D) Endovascular
thrombectomy without thrombolysis.
● The Answer: B (Tenecteplase 0.25 mg/kg as a single 5-10 second intravenous bolus).
● Distractor Analysis: Option A is effective but lacks the rapid single-bolus operational
advantage. Option C is reserved for non-disabling deficits. Option D ignores the mandate
for chemical reperfusion prior to mechanical extraction if eligible.
● The Mentor's Analysis: Tenecteplase (TNK) has achieved primary guideline
endorsement due to its single-bolus administration, higher fibrin specificity, and
non-inferiority to alteplase. This radically accelerates door-to-needle times in critical
settings.
Q4: A clinician is managing a patient newly diagnosed with Heart Failure with reduced
Ejection Fraction (HFrEF). To adhere to 2026 Guideline-Directed Medical Therapy (GDMT),
which medication class should be initiated irrespective of the patient's diabetes status?
A) Thiazide diuretics. B) Calcium channel blockers. C) Sodium-glucose cotransporter-2
inhibitors (SGLT2i). D) Alpha-adrenergic blockers.
● The Answer: C (Sodium-glucose cotransporter-2 inhibitors).
● Distractor Analysis: Options A, B, and D do not provide foundational mortality reduction
in HFrEF. Calcium channel blockers can actively exacerbate HFrEF by exerting negative
inotropic effects.
● The Mentor's Analysis: SGLT2 inhibitors (e.g., dapagliflozin) have transitioned from
exclusive antidiabetic agents to foundational heart failure pillars. They reduce HF
hospitalizations and cardiovascular mortality regardless of Type 2 Diabetes presence by
improving myocardial energetics and reducing afterload.
Q5: A patient with a history of hypertension presents for a routine clinic visit. The
clinician documents an average blood pressure of 132/82 mmHg. According to the
2025/2026 AHA/ACC guidelines, what is the target blood pressure goal for this patient? A)
< 140/90 mmHg. B) < 130/80 mmHg. C) < 120/80 mmHg. D) < 150/90 mmHg.
● The Answer: B (< 130/80 mmHg).
● Distractor Analysis: Options A and D represent outdated, permissive targets that leave
patients at high risk for target organ damage. Option C is a secondary goal strictly for
, patients with very high cardiovascular or kidney risk, but <130/80 is the universal primary
target.
● The Mentor's Analysis: The 2026 standard aggressively targets <130/80 mmHg for all
adults. A reading of 132/82 constitutes Stage 1 Hypertension. If the patient's PREVENT
risk score is ≥7.5%, pharmacological intervention is mandated immediately alongside
lifestyle modifications.
Q6: A patient in the ICU is being treated for Diabetic Ketoacidosis (DKA). The serum
glucose has dropped to 220 mg/dL, but the anion gap remains elevated at 16 mEq/L.
What is the clinician's immediate priority? A) Discontinue the intravenous regular insulin
infusion. B) Transition to subcutaneous insulin glargine. C) Add 5% Dextrose to the intravenous
fluids while continuing the insulin infusion. D) Administer one ampule of sodium bicarbonate.
● The Answer: C (Add 5% Dextrose to the intravenous fluids while continuing the insulin
infusion).
● Distractor Analysis: Option A guarantees a fatal rebound of ketosis. Option B is
premature since the anion gap is not closed. Option D is contraindicated in routine DKA
and causes paradoxical intracellular acidosis.
● The Mentor's Analysis: DKA resolution is defined by the correction of acidosis (closed
anion gap), not merely euglycemia. Adding dextrose prevents hypoglycemia while
allowing the continuous insulin infusion to suppress ketogenesis and fully close the gap.
Q7: A 28-year-old patient with Graves' disease is admitted with a temperature of 39.5°C
(103.1°F), profound agitation, and a heart rate of 155 bpm. Which intervention must be
executed to block peripheral conversion of T4 to T3? A) Intravenous Amiodarone. B)
High-dose Propranolol. C) Oral Levothyroxine. D) Subcutaneous Heparin.
● The Answer: B (High-dose Propranolol).
● Distractor Analysis: Option A contains iodine and can paradoxically worsen
thyrotoxicosis (Jod-Basedow phenomenon). Option C is strictly contraindicated. Option D
has no impact on thyroid physiology.
● The Mentor's Analysis: In a thyroid storm, beta-blockers (specifically Propranolol)
provide a dual mechanism: they control the lethal sympathetic surge (tachycardia) and
uniquely inhibit the peripheral conversion of inactive T4 into the active T3 hormone,
neutralizing the metabolic crisis.
Q8: A patient arrives at the emergency department in an Addisonian Crisis, presenting
with profound hypotension and hypoglycemia. What is the paramount, first-line
pharmacological intervention? A) Intramuscular Epinephrine. B) Intravenous 100 mg
Hydrocortisone. C) Subcutaneous Glucagon. D) Oral Fludrocortisone.
● The Answer: B (Intravenous 100 mg Hydrocortisone).
● Distractor Analysis: Option A treats anaphylaxis, not adrenal failure. Option C treats
hypoglycemia but fails to address the lack of cortisol driving the cardiovascular collapse.
Option D is for maintenance, not acute crisis.
● The Mentor's Analysis: Addisonian crisis is a fatal deficiency of cortisol leading to
vasopressor-resistant shock. Immediate administration of IV Hydrocortisone provides both
glucocorticoid and mineralocorticoid coverage, instantly stabilizing the vascular bed.
Q9: According to the 2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD)
report, what characterizes a "low disease activity state" as the primary treatment target?
A) An FEV1/FVC ratio > 0.80. B) Eradication of all lung hyperinflation. C) No exacerbations, no
worsening of symptoms, and no acceleration in lung function loss. D) Complete reliance on
short-acting bronchodilators.
● The Answer: C (No exacerbations, no worsening of symptoms, and no acceleration in
Exam: Elite 2026/2027 Test Bank
Protocol
PART I: THE PRIMER
Mastering high-acuity medical-surgical nursing transforms the amateur into the apex clinical
leader capable of averting multi-system failure. The 2026/2027 standard demands zero
hesitation, replacing academic memorization with absolute physiological command.
● Sepsis (2025/2026): Shock (MAP < 65 or Lactate ≥ 4) triggers the STAT 1-Hour Bundle;
deploy peripheral norepinephrine without waiting for central access.
● Burns: Initiate 2 mL/kg/%TBSA for adults ≥20% TBSA; abandon static formulas and
titrate hourly to a 30-50 mL/hr urine output.
● Stroke: Tenecteplase (TNK) 0.25 mg/kg is the 2026 standard for rapid bolus
administration within 4.5 hours.
● Heart Failure: SGLT2 inhibitors and ARNis are foundational across ejection fractions;
initiate simultaneously.
● Neuro: Level the External Ventricular Drain (EVD) transducer precisely to the tragus
(Foramen of Monro).
PART II: THE ELITE TEST BANK
Foundational Syntax & Application
Q1: A patient admitted with pneumonia presents with a Mean Arterial Pressure (MAP) of
58 mmHg and a serum lactate of 4.5 mmol/L. According to the 2025/2026 Surviving
Sepsis Campaign guidelines, what is the immediate classification and required timeline
for antimicrobial administration? A) Possible sepsis; 3-hour bundle initiation. B) Septic shock;
1-hour bundle initiation. C) Severe sepsis; 6-hour bundle initiation. D) Systemic Inflammatory
Response Syndrome; 3-hour bundle initiation.
● The Answer: B (Septic shock; 1-hour bundle initiation).
● Distractor Analysis: Options A and D represent outdated or incorrect stratifications. The
3-hour bundle is reserved strictly for "possible sepsis without shock" to allow for rapid
investigation. Option C uses an obsolete 6-hour metric.
● The Mentor's Analysis: The 2026 standard defines a lactate ≥4 mmol/L or hypotension
requiring vasopressors as septic shock. This is a STAT emergency demanding the 1-hour
bundle: broad-spectrum antimicrobials and fluid resuscitation immediately.
Sepsis Acuity Diagnostic Criteria Antimicrobial Timeline
Septic Shock MAP < 65 mmHg OR Lactate ≥ 1-Hour Bundle (STAT
4 mmol/L Emergency)
Possible Sepsis Hemodynamically stable, 3-Hour Bundle (Rapid
uncertain diagnosis Investigation)
,Q2: A 45-year-old male arrives at the emergency department weighing 100 kg with deep
partial-thickness burns over 40% of his Total Body Surface Area (TBSA). Utilizing the
2026 American Burn Association (ABA) Clinical Practice Guidelines, what is the initial
fluid resuscitation rate? A) 1,000 mL/hr of Lactated Ringer's. B) 2,000 mL/hr of 0.9% Normal
Saline. C) 500 mL/hr of Lactated Ringer's. D) 800 mL/hr of 5% Albumin.
● The Answer: C (500 mL/hr of Lactated Ringer's).
● Distractor Analysis: Option A uses the outdated 4 mL/kg Parkland formula (4x100x40 =
16, = 8,000 in 8 hrs = 1,000 mL/hr), which frequently causes fatal
over-resuscitation. Option B uses the wrong crystalloid. Option D introduces colloids too
early.
● The Mentor's Analysis: The 2026 ABA standard initiates resuscitation at 2
mL/kg/%TBSA. Calculation: 2 mL x 100 kg x 40 = 8,000 mL total for 24 hours. Half (4,000
mL) is given in the first 8 hours, resulting in a starting rate of 500 mL/hr. This mitigates
"fluid creep" while maintaining organ perfusion.
Q3: A patient is diagnosed with an acute ischemic stroke (AIS) 2 hours after symptom
onset. Following the 2026 AHA/ASA guidelines, which thrombolytic intervention
demonstrates superior pharmacokinetic advantages and is strongly endorsed? A)
Alteplase 0.9 mg/kg as a continuous 60-minute infusion. B) Tenecteplase 0.25 mg/kg as a single
5-10 second intravenous bolus. C) Dual antiplatelet therapy (DAPT) alone. D) Endovascular
thrombectomy without thrombolysis.
● The Answer: B (Tenecteplase 0.25 mg/kg as a single 5-10 second intravenous bolus).
● Distractor Analysis: Option A is effective but lacks the rapid single-bolus operational
advantage. Option C is reserved for non-disabling deficits. Option D ignores the mandate
for chemical reperfusion prior to mechanical extraction if eligible.
● The Mentor's Analysis: Tenecteplase (TNK) has achieved primary guideline
endorsement due to its single-bolus administration, higher fibrin specificity, and
non-inferiority to alteplase. This radically accelerates door-to-needle times in critical
settings.
Q4: A clinician is managing a patient newly diagnosed with Heart Failure with reduced
Ejection Fraction (HFrEF). To adhere to 2026 Guideline-Directed Medical Therapy (GDMT),
which medication class should be initiated irrespective of the patient's diabetes status?
A) Thiazide diuretics. B) Calcium channel blockers. C) Sodium-glucose cotransporter-2
inhibitors (SGLT2i). D) Alpha-adrenergic blockers.
● The Answer: C (Sodium-glucose cotransporter-2 inhibitors).
● Distractor Analysis: Options A, B, and D do not provide foundational mortality reduction
in HFrEF. Calcium channel blockers can actively exacerbate HFrEF by exerting negative
inotropic effects.
● The Mentor's Analysis: SGLT2 inhibitors (e.g., dapagliflozin) have transitioned from
exclusive antidiabetic agents to foundational heart failure pillars. They reduce HF
hospitalizations and cardiovascular mortality regardless of Type 2 Diabetes presence by
improving myocardial energetics and reducing afterload.
Q5: A patient with a history of hypertension presents for a routine clinic visit. The
clinician documents an average blood pressure of 132/82 mmHg. According to the
2025/2026 AHA/ACC guidelines, what is the target blood pressure goal for this patient? A)
< 140/90 mmHg. B) < 130/80 mmHg. C) < 120/80 mmHg. D) < 150/90 mmHg.
● The Answer: B (< 130/80 mmHg).
● Distractor Analysis: Options A and D represent outdated, permissive targets that leave
patients at high risk for target organ damage. Option C is a secondary goal strictly for
, patients with very high cardiovascular or kidney risk, but <130/80 is the universal primary
target.
● The Mentor's Analysis: The 2026 standard aggressively targets <130/80 mmHg for all
adults. A reading of 132/82 constitutes Stage 1 Hypertension. If the patient's PREVENT
risk score is ≥7.5%, pharmacological intervention is mandated immediately alongside
lifestyle modifications.
Q6: A patient in the ICU is being treated for Diabetic Ketoacidosis (DKA). The serum
glucose has dropped to 220 mg/dL, but the anion gap remains elevated at 16 mEq/L.
What is the clinician's immediate priority? A) Discontinue the intravenous regular insulin
infusion. B) Transition to subcutaneous insulin glargine. C) Add 5% Dextrose to the intravenous
fluids while continuing the insulin infusion. D) Administer one ampule of sodium bicarbonate.
● The Answer: C (Add 5% Dextrose to the intravenous fluids while continuing the insulin
infusion).
● Distractor Analysis: Option A guarantees a fatal rebound of ketosis. Option B is
premature since the anion gap is not closed. Option D is contraindicated in routine DKA
and causes paradoxical intracellular acidosis.
● The Mentor's Analysis: DKA resolution is defined by the correction of acidosis (closed
anion gap), not merely euglycemia. Adding dextrose prevents hypoglycemia while
allowing the continuous insulin infusion to suppress ketogenesis and fully close the gap.
Q7: A 28-year-old patient with Graves' disease is admitted with a temperature of 39.5°C
(103.1°F), profound agitation, and a heart rate of 155 bpm. Which intervention must be
executed to block peripheral conversion of T4 to T3? A) Intravenous Amiodarone. B)
High-dose Propranolol. C) Oral Levothyroxine. D) Subcutaneous Heparin.
● The Answer: B (High-dose Propranolol).
● Distractor Analysis: Option A contains iodine and can paradoxically worsen
thyrotoxicosis (Jod-Basedow phenomenon). Option C is strictly contraindicated. Option D
has no impact on thyroid physiology.
● The Mentor's Analysis: In a thyroid storm, beta-blockers (specifically Propranolol)
provide a dual mechanism: they control the lethal sympathetic surge (tachycardia) and
uniquely inhibit the peripheral conversion of inactive T4 into the active T3 hormone,
neutralizing the metabolic crisis.
Q8: A patient arrives at the emergency department in an Addisonian Crisis, presenting
with profound hypotension and hypoglycemia. What is the paramount, first-line
pharmacological intervention? A) Intramuscular Epinephrine. B) Intravenous 100 mg
Hydrocortisone. C) Subcutaneous Glucagon. D) Oral Fludrocortisone.
● The Answer: B (Intravenous 100 mg Hydrocortisone).
● Distractor Analysis: Option A treats anaphylaxis, not adrenal failure. Option C treats
hypoglycemia but fails to address the lack of cortisol driving the cardiovascular collapse.
Option D is for maintenance, not acute crisis.
● The Mentor's Analysis: Addisonian crisis is a fatal deficiency of cortisol leading to
vasopressor-resistant shock. Immediate administration of IV Hydrocortisone provides both
glucocorticoid and mineralocorticoid coverage, instantly stabilizing the vascular bed.
Q9: According to the 2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD)
report, what characterizes a "low disease activity state" as the primary treatment target?
A) An FEV1/FVC ratio > 0.80. B) Eradication of all lung hyperinflation. C) No exacerbations, no
worsening of symptoms, and no acceleration in lung function loss. D) Complete reliance on
short-acting bronchodilators.
● The Answer: C (No exacerbations, no worsening of symptoms, and no acceleration in
